Skip to main content
. 2023 Sep 4;16(1):803–810. doi: 10.1159/000533377

Table 2.

Results of the comprehensive genomic profiling of the metastatic CRC to the left kidney

Gene Genomic alteration
PDL1
PDL2 Amplification (9p24.1 amplicon)
JAK2
KRAS Amplification
CCND2 Amplification
APC Mutation (V1320 fs*11, R283*)
CDK8 Amplification (equivocal)
FGF23 Amplification
FGF6 Amplification
FLT3 Amplification (equivocal)
KDM5A Amplification
TP53 Mutation (S241 fs*19)
CDH1 Loss in exons 1–2
Additional findings
 MSI status MS-stable
 TMB Four mutations/mb